In Our Democracy^TM, Science^TM and our “leaders” aren’t doing a very good job

Derivatives and the Banking System

With the failure and bailout of SVB Bank and Signature Bank, the FDIC insurance fund, which is supposed to bail out banks when they fail, is bankrupt. This banking insurance fund only had $100 billion or so before the collapse of SVB and Signature. SVB had about $150 billion in unsecured deposits, and Signature had about $50 billion. The rest of the bailout money was printed by the Fed. If another regional bank (perhaps your bank) collapses due to rising interest rates and falling bond prices, where will the “money” come from to bail it out? Sorry folks, there aint no money left. The elite venture capitalists already got theirs, and bankrupted the system. Mr. Potter doesn’t have any money left for the hard working taxpayers.

First Republic Bank is also on shaky ground. On Thursday 11 major US banks pledged to deposit $30 billion into it. This does not bode well for our banking system.

Our elites are destroying the economy and swooping up the assets and the remaining wealth of this country, causing bank runs on their own banks, and sending over $100 billion for a proxy war in Ukraine against Russia. The War in Ukraine has morphed from defending the Ukrainian people into a sophisticated money laundering operation, while the people are lied to by our so-called “leaders.” The corruption in both banking and government is becoming more and more visible to the public.

As shaky as the system is now, there’s an even bigger problem. No one talks about derivatives, the elephant in the room. Derivatives are financial contracts set between two or more parties that derive their value from an underlying asset or group of assets, such as a group of mortgages, stocks, bonds, or commodities. The problem is that although derivatives can be used to reduce risk (hedging), they are far more likely to be used to speculate on the price movement of an underlying asset, or to leverage holdings. A leveraged financial instrument can be purchased with only a small amount of capital and gives you an interest in a much larger amount of value in the underlying asset. So you can invest, with just a little cash, in a very large number of markets and financial instruments. In the process, of course, you spread you money very, very thin.

As more and more derivatives – such as collateralized mortgage obligations, which are tranches or slices of a pool of mortgages – are created on top of the original pool of mortgages, they become more and more detached from the real asset. Investment banks have been creating derivatives for decades as a way to make money. But many of these derivative contracts cannot even be valued – they cannot be “marked to market.” That is because many of these financial instruments are so far removed from the real asset that they are essentially valueless.

Ok, so no big deal, right? Our Tresury Secretary, Janet Yellen, tells us that the banking system is “sound.” Not being one to trust politicians, out of curiosity I looked up the exposure of U.S. banks to derivatives. I couldn’t believe what I found. This is a screenshot of partial list of banks.

Source: https://www.usbanklocations.com/bank-rank/derivatives.html

Check out the first three investment banks – three of 20 Big Banks (banks that are “too big to fail”) that handle U.S. Treasury auctions and which collect substantial fees for doing so.

Leading the pack is Goldman Sachs, with over $53 trillion in derivatives. Uh, excuse me. $50 TRILLION? How the hell can a bank have that much exposure on their books?

It comes from greed and unbridled speculation. Note that the values listed here are par values. Meaning that this is what the banks themselves determine is their worth. The real value of many of these derivatives aren’t even close to the par value, but the banks can’t admit that or they will all collapse. Neither can the bank regulators. Oops! Also note that this isn’t new information. A banker would yawn at this essay. It’s common knowledge at the Fed, and the government oversight committees in Congress, at the FDIC and the SEC.

The next two banks all have around $50 trillion in derivatives on their books. If you go to this website and add up these figures, you get an astonishing total of about $193 trillion dollars in derivatives on the books of U.S. banks (that was my quick calculation).

And we wonder why banks are in trouble?

Go to the website and check the list to see where your bank stands. The list is longer than the image here.

The graph above just lists the derivatives held by banks in the US. According to Investopedia,

The derivatives market is, in a word, gigantic—often estimated at over $1 quadrillion on the high end. How can that be? Largely because there are numerous derivatives in existence, available on virtually every possible type of investment asset, including equities, commodities, bonds, and currency. Some market analysts even place the size of the market at more than 10 times that of the total world gross domestic product (GDP).”

https://www.investopedia.com/terms/d/derivative.asp

Wow.

Again, the values in this table are the dollar amounts that the banks assign to the worth of their derivatives. This is called the notional value, or face value.

“Notional value is a term used to value the underlying asset in a derivatives trade. The notional, or face, value of derivatives contracts is much higher than the market value due to the use of leverage, or borrowed money.”

The derivative game is played by investment banks assigning dollar values to their own portfolios. The derivatives market, worldwide, is a gigantic albatross around the neck of the world’s financial system.

It’s a nice gig, isn’t it? Hey, why don’t you get a printing press and start printing money in your basement? That’s what the derivatives market essentially does. If you or I were to do this we would be – rightly – thrown in jail.

Investment banks have the ability to literally create financial instruments that are backed by nothing, just like the fiat money currencies such as the dollar and the euro.

So the next time you hear rich guys – like the venture capitalists in SVC Bank, whose investors started a run on their own bank – cry about bailouts, take it with a grain of salt. The gummint bailed out the rich depositors in SVC Bank and Signature Bank, and bankrupted the FDIC’s bank insurance fund.

In my opinion, the banking system must be reset to wipe out all so-called “assets” that cannot be marked to market. But what do I know? I’m no expert.

Who is Running Our World?

So far we are on pretty solid ground. Now let’s get into the realm of speculation.

First, remember that the internet began as a secure, closed information-sharing network of the U.S. Department of Defense and research institutions, called ARPANET. What they don’t tell you is that one of the goals of this network was to engage in weapons research at various universities across the country. That’s why the military created the network in the first place, in my opinion.

We also know that the Patent Office has confiscated thousands of inventions that the military and the intelligence community consider threats to “national security.” According to Wired (and many other sources),

Government Secrecy Orders on Patents Have Stifled More Than 5,000 Inventions. If the government thinks your patent-pending invention has national security implications, it can slap a secrecy order on it that prevents you from developing it. More than 5,300 such orders have been issued, with some of them in effect for decades.”

https://www.wired.com/2013/04/gov-secrecy-orders-on-patents/

If the Department of Defense thinks your invention is a threat to national security – which means, the established order – it can slap a Patent Secrecy Order on your invention. Which means you can’t commercialize it or even publicize it. Your invention just sits at the Patent Office.

According to Wired, “Tens of thousands of patent applications are manually examined each year under the Invention Secrecy Act and referred for a final decision to the Pentagon, National Security Agency, Department of Justice and, more recently, Department of Homeland Security.” Yeah. These outfits all belong to the military/intelligence complex.

But what happens to your invention after it gets sequestered? Well, as far as I can tell, it’s stolen, basically. An entire industry has been built around cutting-edge inventions that have been stolen from U.S. inventors. These inventions are monetized by venture capitalists (at places like the CIA and SVB Bank, the one that just failed and got bailed out.)

To see how the CIA monetizes patent information, let’s take a peek at In-Q-Tel, the CIA’s venture capital outfit. The name of the website is iqt.org. If you click on the “Portfolio” link (iqt.org/portfolio) you can see hundreds of cutting edge organizations sponsored by the CIA. This is just a screenshot of part of the first page:

These CIA-created/sponsored companies are creating high-tech startups using technology stolen from American inventors under the guise of national security. Some of this technology is being weaponized. But of course, it’s all in a good cause! Serving the interests of America’s elite millionaires and billionaires, and hidden cliques within the secret national security and intelligence community.

How many billions (or trillions) of dollars have CIA funded companies like this made over the years? Scroll through the portfolio section on the In-Q-Tel website and click on some of these companies. The CIA is engaging in cutting-edge tech in every imaginable field, funded by taxpayer money, and we have no say in what is being researched, or how that research will be applied to American society and the economy.

We can conclude by saying that innovation in technology is driven by a control paradigm, and it is managed by insiders in the military and in the intelligence community.

How do you like them apples?

But no worries, folks. Treasury Secretary Janet Yellen and President Joe Biden tell us that the banking system is “sound.” Like the avalanche of phony derivatives held by our banks, these people are divorced from reality. But remember folks. In Our Democracy^TM, Science^TM and our “leaders” are working for the best interests of the people!

[1] https://world101.cfr.org/global-era-issues/cyberspace-and-cybersecurity/origins-internet

Welcome to the medical surveillance state.

...the U.S. government has secretly been tracking those who didn’t get the COVID jab, or are only partially jabbed, through a previously unknown surveillance program designed by the U.S. National Center for Health Statistics (NCHS), a division of the Centers for Disease Control and Prevention (CDC)

The program was implemented on April 1, 2022, but didn’t become universally adopted by most medical clinics and hospitals across the United States until January 2023.

"Under this program, doctors at clinics and hospitals have been instructed to ask patients about their vaccination status, which is then added to their electronic medical records as a diagnostic code, known as ICD-10 code, without their knowledge or consent so that they can be tracked—not just within the health care system but outside of it as well.

https://www.theepochtimes.com/health/the-federal-government-is-tracking-the-unvaccinated_5056313.html

By "partially jabbed" is meant anyone who is not current on any recommended vaccine.

For example, ICD-10 code Z28.310 identifies those who have not received a COVID jab and Z28.311 identifies those who are not up to date on their shots. [emphasis mine]

EVs make perfect sense for people who have in-home solar power arrays and are concerned with their carbon footprint

There are good reasons to buy an all-electric vehicle. Among them are, according to Car and Driver,

An electric car's mechanisms tend to be much simpler than those of a standard-powered vehicle. A few examples listed by My EV include the following:

An electric motor has fewer moving parts than a gasoline engine.

An electric car is fitted with a single-speed transmission.

Unlike conventional automobiles, electric cars are not equipped with many of the usual parts that eventually break and need to be replaced or repaired.”

https://www.caranddriver.com/research/a31875141/electric-car-battery-life/

However, many people buy EVs because they are “far easier on the environment.”

But is this really true?  

According to CNBC,

Almost all studies have shown that the production of electric cars causes more harm to the environment than the production of a combustion car. This is primarily because of the heavy battery used in electric cars. So, if the production of a fuel car releases 10 metric tonnes of carbon dioxide, the manufacturing of an EV generates 15.3 metric tonnes of carbon dioxide.

However, fuel cars lose this edge when it comes to the usage of the vehicle. According to the United States Department of Energy, an average fuel car releases 5.2 metric tonnes of carbon dioxide per year. The figure has been reached after keeping the yearly commute distance at 19,300 km. On the other hand, a study by the Alternative Fuel Data Centre of the US reveals that an electric car produces 2.2 metric tonnes of carbon dioxide for the same distance.

Using this emission data, it is safe to conclude that an electric car and a fuel car are equally harmful to the environment for the first 20 months or so. The difference kicks in thereafter. After the first 20 months, electric cars are way less polluting than their ICE-powered counterparts.

Even if we extend this EV vs ICE debate to lithium extraction and oil drilling, electric cars will still be the slightly better option. Skeptics of EVs often point out that the extraction of lithium-ion — a crucial component of EVs — is damaging to the environment. While the argument is not without merit, it must also be taken into consideration that lithium ions make up for just 5–7 percent of the EV battery. Further, lithium extraction, although a water-intensive process, takes place in desolate places where no life can survive. For instance, the Atacama desert in Chile. In contrast, oil drilling takes place on ocean beds which disrupts marine life in the area.”

https://www.cnbctv18.com/auto/evs-or-fuel-cars--comparing-their-carbon-footprints-12184562.htm

This argument in support of EVs, however, does not take into account the other metals that go into making an EV battery. The average EV car battery weighs between 500 and 1,000 pounds. If lithium ions make up only 5% to 7% of the EV car battery, where do the other hundreds of pounds of material come from? It turns out that in addition to lithium, the materials to make an EV battery consist of cobalt, nickel, graphite, copper, and steel. All of these metals come from the earth and must be mined. Not only are mines ugly but they destroy the surface and pollute rivers and the surrounding land.

So, the EV– internal combustion debate as to environmental safety is, in my opinion, a draw. EVs are not environmental panaceas, they may at best be a “slightly better option” than internal combustion vehicles.

Here are some things to consider before buying an EV:

1) The obvious: If you do not have a solar power array at home, the energy to charge your EV comes from the fossil fuel grid, and that grid burns oil, gas, and coal (or exhausts nuclear fuel). Every time you charge your EV you are increasing your carbon footprint.

2) EV batteries are unnecessarily large. Most EVs can go from 0 to 60 in less than 3 seconds! The power to achieve this amazing power surge, however, drains the battery faster and requires a larger battery, and thus more material extracted from mother earth.

3) Driving an EV to the limit of its range heavily discharges the battery pack. Regularly discharging an EV battery reduces the life of the battery. This means the range of your EV, for practical purposes, is reduced.  

4) Fast charging your EV only gets you an 80% charge, which means you have to stop and recharge more often. Moreover, Fast-charging stresses the battery. According to Car and Driver, “Another thing that can diminish batteries lifespan is using Level 3 fast-charging stations. These stations can charge the battery up to 80% in 30 minutes, but they can also overheat the battery. Carfax warns that this can affect the battery's long-term performance and longevity.”

5) Leaving an EV outside in the garage – in the heat or cold – will result in a reduced range when you get up the next day to drive it. EVs burn power even when they aren’t being used, because their powered heating (and cooling) systems are always on, to keep the battery from getting too cold or too hot. That means keeping the vehicle plugged in to avoid loss of charge while it’s just sitting there. And if you don’t have a solar array at home, you are increasing your carbon footprint.

6) Finally, if you want to fast charge your EV at home you have to rewire your home’s electrical system to commercial grade. The standard 240 volt charging system for at-home charging takes between 8 and 9 hours for a full charge. Otherwise you have to drive to a charging station.

The good news for EV owners is that although the average EV battery currently lasts about 8–10 years, the cost of replacement is going down. However, the more EVs are sold the more mineral extraction is necessary, which means that more of the earth’s surface is torn up to extract the minerals and metals necessary to make them, thus increasing the carbon footprint for the EV industry. Moreover, 80% of EV car batteries are made in China. The more EVs are sold the more we help the Chinese economy, when our own workers are suffering from high inflation and a lack of jobs.

However, the EV supply problem is likely to solve itself. There simply might not be enough lithium to manufacture the 2.5 billion EVs necessary for the world to achieve net carbon zero emissions.

According to Ian Shine at weforum.org,

The International Energy Agency says the world could face lithium shortages by 2025. And Credit Suisse says lithium demand could treble between 2020 and 2025, meaning “supply would be stretched.” 

The campaign group Transport and Environment says there is only enough lithium to produce up to 14 million EVs in 2023, Reuters reports. “There simply isn’t going to be enough lithium on the face of the planet, regardless of who expands and who delivers, it just won’t be there,” Lake Resources Chairman Stuart Crow told the Financial Times. “Car makers are starting to sense that maybe the battery makers aren’t going to be able to deliver.”

Volkswagen, the world’s second-largest car manufacturer, has already sold out of EVs in the US and Europe for 2022. Ford’s E-Transit van sold out before production had even begun.”

https://www.weforum.org/agenda/2022/07/electric-vehicles-world-enough-lithium-resources/

Conclusion

All-electric vehicles are a great idea for people with a solar installation at home, for their emissions footprint should be greatly reduced when compared to a gas powered vehicle. For those without solar arrays, charging your EV uses energy from the polluting fossil fuel grid, and your overall carbon footprint for the life of the EV probably isn’t much different compared to a gasoline powered vehicle.  

Transhumanist insanity is now officially promoted by our own government

The Biden administration has just issued a new Executive Order, “Executive Order on Advancing Biotechnology and Biomanufacturing Innovation for a Sustainable, Safe, and Secure American Bioeconomy,” September 12, 2022. With this EO the U.S. government is putting into immediate motion a totalitarian bio-surveillance state where the government owns and programs your biology.

If this insane Transhumanist plan is implemented, the government will own every cell in your body. Don’t believe me? Here is the most relevant portion of this EO:

The United States needs to invest in foundational scientific capabilities.  We need to develop genetic engineering technologies and techniques to be able to write circuitry for cells and predictably program biology in the same way in which we write software and program computers; unlock the power of biological data, including through computing tools and artificial intelligence..."

What is “biological data? Toward the end of this EO it is defined:

(e) The term “biological data” means the information, including associated descriptors, derived from the structure, function, or process of a biological system(s) that is measured, collected, or aggregated for analysis."

New Executive Order

Is further elaboration necessary? This EO is an in-your-face, dystopian plan to phase out human biology and to create a programmed Borg, “Human 2.0” society.

I suggest you read this all the way through.

Under the guise of  “climate change,” “sustainability,” and “equity, ethics, safety, and security,” this EO outlines the plan our elites have for the human race.

Midterms are coming up in November. We must vote out any politician who supports this attack on humanity.

The basis for this Executive Order is Transhumanist technology, which was outlined by Renee Wygrzyn during her talk at the Long Now Foundation.

Here is the document in full:

THE WHITE HOUSE

Executive Order on Advancing Biotechnology and Biomanufacturing Innovation for a Sustainable, Safe, and Secure American Bioeconomy

SEPTEMBER 12, 2022

•

PRESIDENTIAL ACTIONS

By the authority vested in me as President by the Constitution and the laws of the United States of America, it is hereby ordered as follows:

Section 1.  Policy.  It is the policy of my Administration to coordinate a whole-of-government approach to advance biotechnology and biomanufacturing towards innovative solutions in health, climate change, energy, food security, agriculture, supply chain resilience, and national and economic security.  Central to this policy and its outcomes are principles of equity, ethics, safety, and security that enable access to technologies, processes, and products in a manner that benefits all Americans and the global community and that maintains United States technological leadership and economic competitiveness.

Biotechnology harnesses the power of biology to create new services and products, which provide opportunities to grow the United States economy and workforce and improve the quality of our lives and the environment.  The economic activity derived from biotechnology and biomanufacturing is referred to as “the bioeconomy.”  The COVID-19 pandemic has demonstrated the vital role of biotechnology and biomanufacturing in developing and producing life-saving diagnostics, therapeutics, and vaccines that protect Americans and the world.  Although the power of these technologies is most vivid at the moment in the context of human health, biotechnology and biomanufacturing can also be used to achieve our climate and energy goals, improve food security and sustainability, secure our supply chains, and grow the economy across all of America.

For biotechnology and biomanufacturing to help us achieve our societal goals, the United States needs to invest in foundational scientific capabilities.  We need to develop genetic engineering technologies and techniques to be able to write circuitry for cells and predictably program biology in the same way in which we write software and program computers; unlock the power of biological data, including through computing tools and artificial intelligence; and advance the science of scale‑up production while reducing the obstacles for commercialization so that innovative technologies and products can reach markets faster.

Simultaneously, we must take concrete steps to reduce biological risks associated with advances in biotechnology.  We need to invest in and promote biosafety and biosecurity to ensure that biotechnology is developed and deployed in ways that align with United States principles and values and international best practices, and not in ways that lead to accidental or deliberate harm to people, animals, or the environment.  In addition, we must safeguard the United States bioeconomy, as foreign adversaries and strategic competitors alike use legal and illegal means to acquire United States technologies and data, including biological data, and proprietary or precompetitive information, which threatens United States economic competitiveness and national security.

We also must ensure that uses of biotechnology and biomanufacturing are ethical and responsible; are centered on a foundation of equity and public good, consistent with Executive Order 13985 of January 20, 2021 (Advancing Racial Equity and Support for Underserved Communities Through the Federal Government); and are consistent with respect for human rights.  Resources should be invested justly and equitably so that biotechnology and biomanufacturing technologies benefit all Americans, especially those in underserved communities, as well as the broader global community.

To achieve these objectives, it is the policy of my Administration to:

(a)  bolster and coordinate Federal investment in key research and development (R&D) areas of biotechnology and biomanufacturing in order to further societal goals;

(b)  foster a biological data ecosystem that advances biotechnology and biomanufacturing innovation, while adhering to principles of security, privacy, and responsible conduct of research;

(c)  improve and expand domestic biomanufacturing production capacity and processes, while also increasing piloting and prototyping efforts in biotechnology and biomanufacturing to accelerate the translation of basic research results into practice;

(d)  boost sustainable biomass production and create climate-smart incentives for American agricultural producers and forest landowners;

(e)  expand market opportunities for bioenergy and biobased products and services;

(f)  train and support a diverse, skilled workforce and a next generation of leaders from diverse groups to advance biotechnology and biomanufacturing;

(g)  clarify and streamline regulations in service of a science- and risk-based, predictable, efficient, and transparent system to support the safe use of products of biotechnology;

(h)  elevate biological risk management as a cornerstone of the life cycle of biotechnology and biomanufacturing R&D, including by providing for research and investment in applied biosafety and biosecurity innovation;

(i)  promote standards, establish metrics, and develop systems to grow and assess the state of the bioeconomy; to better inform policy, decision-making, and investments in the bioeconomy; and to ensure equitable and ethical development of the bioeconomy;

(j)  secure and protect the United States bioeconomy by adopting a forward‑looking, proactive approach to assessing and anticipating threats, risks, and potential vulnerabilities (including digital intrusion, manipulation, and exfiltration efforts by foreign adversaries), and by partnering with the private sector and other relevant stakeholders to jointly mitigate risks to protect technology leadership and economic competitiveness; and

(k)  engage the international community to enhance biotechnology R&D cooperation in a way that is consistent with United States principles and values and that promotes best practices for safe and secure biotechnology and biomanufacturing research, innovation, and product development and use.

The efforts undertaken pursuant to this order to further these policies shall be referred to collectively as the National Biotechnology and Biomanufacturing Initiative.

Sec. 2.  Coordination.  The Assistant to the President for National Security Affairs (APNSA), in consultation with the Assistant to the President for Economic Policy (APEP) and the Director of the Office of Science and Technology Policy (OSTP), shall coordinate the executive branch actions necessary to implement this order through the interagency process described in National Security Memorandum 2 of February 4, 2021 (Renewing the National Security Council System) (NSM-2 process).  In implementing this order, heads of agencies (as defined in section 13 of this order) shall, as appropriate and consistent with applicable law, consult outside stakeholders, such as those in industry; academia; nongovernmental organizations; communities; labor unions; and State, local, Tribal, and territorial governments to advance the policies described in section 1 of this order.

Sec. 3.  Harnessing Biotechnology and Biomanufacturing R&D to Further Societal Goals.  (a)  Within 180 days of the date of this order, the heads of agencies specified in subsections (a)(i)-(v) of this section shall submit the following reports on biotechnology and biomanufacturing to further societal goals related to health, climate change and energy, food and agricultural innovation, resilient supply chains, and cross-cutting scientific advances.  The reports shall be submitted to the President through the APNSA, in coordination with the Director of the Office of Management and Budget (OMB), the APEP, the Assistant to the President for Domestic Policy (APDP), and the Director of OSTP.

(i)    The Secretary of Health and Human Services (HHS), in consultation with the heads of appropriate agencies as determined by the Secretary, shall submit a report assessing how to use biotechnology and biomanufacturing to achieve medical breakthroughs, reduce the overall burden of disease, and improve health outcomes.

(ii)   The Secretary of Energy, in consultation with the heads of appropriate agencies as determined by the Secretary, shall submit a report assessing how to use biotechnology, biomanufacturing, bioenergy, and biobased products to address the causes and adapt to and mitigate the impacts of climate change, including by sequestering carbon and reducing greenhouse gas emissions.

(iii)  The Secretary of Agriculture, in consultation with the heads of appropriate agencies as determined by the Secretary, shall submit a report assessing how to use biotechnology and biomanufacturing for food and agriculture innovation, including by improving sustainability and land conservation; increasing food quality and nutrition; increasing and protecting agricultural yields; protecting against plant and animal pests and diseases; and cultivating alternative food sources.

(iv)   The Secretary of Commerce, in consultation with the Secretary of Defense, the Secretary of HHS, and the heads of other appropriate agencies as determined by the Secretary of Commerce, shall submit a report assessing how to use biotechnology and biomanufacturing to strengthen the resilience of United States supply chains.

(v)    The Director of the National Science Foundation (NSF), in consultation with the heads of appropriate agencies as determined by the Director, shall submit a report identifying high-priority fundamental and use‑inspired basic research goals to advance biotechnology and biomanufacturing and to address the societal goals identified in this section.

(b)  Each report specified in subsection (a) of this section shall identify high-priority basic research and technology development needs to achieve the overall objectives described in subsection (a) of this section, as well as opportunities for public-private collaboration.  Each of these reports shall also include recommendations for actions to enhance biosafety and biosecurity to reduce risk throughout the biotechnology R&D and biomanufacturing lifecycles.

(c)  Within 100 days of receiving the reports required under subsection (a) of this section, the Director of OSTP, in coordination with the Director of OMB, the APNSA, the APEP, the APDP, and the heads of appropriate agencies as determined through the NSM-2 process, shall develop a plan (implementation plan) to implement the recommendations in the reports.  The development of this implementation plan shall also include the solicitation of input from external experts regarding potential ethical implications or other societal impacts, including environmental sustainability and environmental justice, of the recommendations contained in the reports required under subsection (a) of this section.  The implementation plan shall include assessments and make recommendations regarding any such implications or impacts.

(d)  Within 90 days of the date of this order, the Director of OMB, in consultation with the heads of appropriate agencies as determined through the NSM-2 process, shall perform a budget crosscut to identify existing levels of agency spending on biotechnology- and biomanufacturing-related activities to inform the development of the implementation plan described in subsection (c) of this section.

(e)  The APNSA, in coordination with the Director of OMB, the APEP, the APDP, and the Director of OSTP, shall review the reports required under subsection (a) of this section and shall submit the reports to the President in an unclassified form, but may include a classified annex.

(f)  The APNSA, in coordination with the Director of OMB, the APEP, the APDP, and the Director of OSTP, shall include a cover memorandum for the reports submitted pursuant to subsection (a) of this section, along with the implementation plan required under subsection (c) of this section, in which they make any additional overall recommendations for advancing biotechnology and biomanufacturing.

(g)  Within 2 years of the date of this order, agencies at which recommendations are directed in the implementation plan required under subsection (c) of this section shall report to the Director of OMB, the APNSA, the APEP, the APDP, and the Director of OSTP on measures taken and resources allocated to enhance biotechnology and biomanufacturing, consistent with the implementation plan described in subsection (c) of this section.

(h)  Within 180 days of the date of this order, the President’s Council of Advisors on Science and Technology shall submit to the President and make publicly available a report on the bioeconomy that provides recommendations on how to maintain United States competitiveness in the global bioeconomy.

Sec. 4.  Data for the Bioeconomy.  (a)  In order to facilitate development of the United States bioeconomy, my Administration shall establish a Data for the Bioeconomy Initiative (Data Initiative) that will ensure that high-quality, wide-ranging, easily accessible, and secure biological data sets can drive breakthroughs for the United States bioeconomy.  To assist in the development of the Data Initiative, the Director of OSTP, in coordination with the Director of OMB and the heads of appropriate agencies as determined by the Director of OSTP, and in consultation with external stakeholders, shall issue a report within 240 days of the date of this order that:

(i)    identifies the data types and sources, to include genomic and multiomic information, that are most critical to drive advances in health, climate, energy, food, agriculture, and biomanufacturing, as well as other bioeconomy-related R&D, along with any data gaps;

(ii)   sets forth a plan to fill any data gaps and make new and existing public data findable, accessible, interoperable, and reusable in ways that are equitable, standardized, secure, and transparent, and that are integrated with platforms that enable the use of advanced computing tools;

(iii)  identifies — based on the data types and sources described in subsection (a)(i) of this section — security, privacy, and other risks (such as malicious misuses, manipulation, exfiltration, and deletion), and provides a data-protection plan to mitigate these risks; and

(iv)   outlines the Federal resources, legal authorities, and actions needed to support the Data Initiative and achieve the goals outlined in this subsection, with a timeline for action.

(b)  The Secretary of Homeland Security, in coordination with the Secretary of Defense, the Secretary of Agriculture, the Secretary of Commerce (acting through the Director of the National Institute of Standards and Technology (NIST)), the Secretary of HHS, the Secretary of Energy, and the Director of OMB, shall identify and recommend relevant cybersecurity best practices for biological data stored on Federal Government information systems, consistent with applicable law and Executive Order 14028 of May 12, 2021 (Improving the Nation’s Cybersecurity).

(c)  The Secretary of Commerce, acting through the Director of NIST and in coordination with the Secretary of HHS, shall consider bio-related software, including software for laboratory equipment, instrumentation, and data management, in establishing baseline security standards for the development of software sold to the United States Government, consistent with section 4 of Executive Order 14028.

Sec. 5.  Building a Vibrant Domestic Biomanufacturing Ecosystem.  (a)  Within 180 days of the date of this order, the APNSA and the APEP, in coordination with the Secretary of Defense, the Secretary of Agriculture, the Secretary of Commerce, the Secretary of HHS, the Secretary of Energy, the Director of NSF, and the Administrator of the National Aeronautics and Space Administration (NASA), shall develop a strategy that identifies policy recommendations to expand domestic biomanufacturing capacity for products spanning the health, energy, agriculture, and industrial sectors, with a focus on advancing equity, improving biomanufacturing processes, and connecting relevant infrastructure.  Additionally, this strategy shall identify actions to mitigate risks posed by foreign adversary involvement in the biomanufacturing supply chain and to enhance biosafety, biosecurity, and cybersecurity in new and existing infrastructure.

(b)  Agencies identified in subsections (b)(i)-(iv) of this section shall direct resources, as appropriate and consistent with applicable law, towards the creation or expansion of programs that support a vibrant domestic biomanufacturing ecosystem, as informed by the strategy developed pursuant to subsection (a) of this section:

(i)    the NSF shall expand its existing Regional Innovation Engine program to advance emerging technologies, including biotechnology;

(ii)   the Department of Commerce shall address challenges in biomanufacturing supply chains and related biotechnology development infrastructure;

(iii)  the Department of Defense shall incentivize the expansion of domestic, flexible industrial biomanufacturing capacity for a wide range of materials that can be used to make a diversity of products for the defense supply chain; and

(iv)   the Department of Energy shall support research to accelerate bioenergy and bioproduct science advances, to accelerate biotechnology and bioinformatics tool development, and to reduce the hurdles to commercialization, including through incentivizing the engineering scale-up of promising biotechnologies and the expansion of biomanufacturing capacity.

(c)  Within 1 year of the date of this order, the Secretary of Agriculture, in consultation with the heads of appropriate agencies as determined by the Secretary, shall submit a plan to the President, through the APNSA and the APEP, to support the resilience of the United States biomass supply chain for domestic biomanufacturing and biobased product manufacturing, while also advancing food security, environmental sustainability, and the needs of underserved communities.  This plan shall include programs to encourage climate-smart production and use of domestic biomass, along with budget estimates, including accounting for funds appropriated for Fiscal Year (FY) 2022 and proposed in the President’s FY 2023 Budget.

(d)  Within 180 days of the date of this order, the Secretary of Homeland Security, in coordination with the heads of appropriate agencies as determined by the Secretary, shall:

(i)   provide the APNSA with vulnerability assessments of the critical infrastructure and national critical functions associated with the bioeconomy, including cyber, physical, and systemic risks, and recommendations to secure and make resilient these components of our infrastructure and economy; and

(ii)  enhance coordination with industry on threat information sharing, vulnerability disclosure, and risk mitigation for cybersecurity and infrastructure risks to the United States bioeconomy, including risks to biological data and related physical and digital infrastructure and devices.  This coordination shall be informed in part by the assessments described in subsection (d)(i) of this section.

Sec. 6.  Biobased Products Procurement.  (a)  Consistent with the requirements of 7 U.S.C. 8102, within 1 year of the date of this order, procuring agencies as defined in 7 U.S.C. 8102(a)(1)(A) that have not yet established a biobased procurement program as described in 7 U.S.C. 8102(a)(2) shall establish such a program.

(b)  Procuring agencies shall require that, within 2 years of the date of this order, all appropriate staff (including contracting officers, purchase card managers, and purchase card holders) complete training on biobased product purchasing.  The Office of Federal Procurement Policy, within OMB, in cooperation with the Secretary of Agriculture, shall provide training materials for procuring agencies.

(c)  Within 180 days of the date of this order and annually thereafter, procuring agencies shall report previous fiscal year spending to the Director of OMB on the following:

(i)    the number and dollar value of contracts entered into during the previous fiscal year that include the direct procurement of biobased products;

(ii)   the number of service and construction (including renovations) contracts entered into during the previous fiscal year that include language on the use of biobased products; and

(iii)  the types and dollar values of biobased products actually used by contractors in carrying out service and construction (including renovations) contracts during the previous fiscal year.

(d)  The requirements in subsection (c) of this section shall not apply to purchase card transactions and other “[a]ctions not reported” to the Federal Procurement Data System pursuant to 48 CFR 4.606(c).

(e)  Within 1 year of the date of this order and annually thereafter, the Director of OMB shall publish information on biobased procurement resulting from the data collected under subsection (c) of this section and information reported under 7 U.S.C. 8102, along with other related information, and shall use scorecards or similar systems to encourage increased biobased purchasing.

(f)  Within 1 year of the date of this order and annually thereafter, procuring agencies shall report to the Secretary of Agriculture specific categories of biobased products that are unavailable to meet their procurement needs, along with desired performance standards for currently unavailable products and other relevant specifications.  The Secretary of Agriculture shall publish this information annually.  When new categories of biobased products become commercially available, the Secretary of Agriculture shall designate new product categories for preferred Federal procurement, as prescribed by 7 U.S.C. 8102.

(g)  Procuring agencies shall strive to increase by 2025 the amount of biobased product obligations or the number or dollar value of biobased-only contracts, as reflected in the information described in subsection (c) of this section, and as appropriate and consistent with applicable law.

Sec. 7.  Biotechnology and Biomanufacturing Workforce.  (a)  The United States Government shall expand training and education opportunities for all Americans in biotechnology and biomanufacturing.  To support this objective, within 200 days of the date of this order, the Secretary of Commerce, the Secretary of Labor, the Secretary of Education, the APDP, the Director of OSTP, and the Director of NSF shall produce and make publicly available a plan to coordinate and use relevant Federal education and training programs, while also recommending new efforts to promote multi-disciplinary education programs.  This plan shall promote the implementation of formal and informal education and training (such as opportunities at technical schools and certificate programs), career and technical education, and expanded career pathways into existing degree programs for biotechnology and biomanufacturing.  This plan shall also include a focused discussion of Historically Black Colleges and Universities, Tribal Colleges and Universities, and Minority Serving Institutions and the extent to which agencies can use existing statutory authorities to promote racial and gender equity and support underserved communities, consistent with the policy established in Executive Order 13985.  Finally, this plan shall account for funds appropriated for FY 2022 and proposed in the President’s FY 2023 Budget.

(b)  Within 2 years of the date of this order, agencies that support relevant Federal education and training programs as described in subsection (a) of this section shall report to the President through the APNSA, in coordination with the Director of OMB, the ADPD, and the Director of OSTP, on measures taken and resources allocated to enhance workforce development pursuant to the plan described in subsection (a) of this section.

Sec. 8.  Biotechnology Regulation Clarity and Efficiency.  Advances in biotechnology are rapidly altering the product landscape.  The complexity of the current regulatory system for biotechnology products can be confusing and create challenges for businesses to navigate.  To improve the clarity and efficiency of the regulatory process for biotechnology products, and to enable products that further the societal goals identified in section 3 of this order, the Secretary of Agriculture, the Administrator of the Environmental Protection Agency, and the Commissioner of Food and Drugs, in coordination with the Director of OMB, the ADPD, and the Director of OSTP, shall:

(a)  within 180 days of the date of this order, identify areas of ambiguity, gaps, or uncertainties in the January 2017 Update to the Coordinated Framework for the Regulation of Biotechnology or in the policy changes made pursuant to Executive Order 13874 of June 11, 2019 (Modernizing the Regulatory Framework for Agricultural Biotechnology Products), including by engaging with developers and external stakeholders, and through horizon scanning for novel products of biotechnology;

(b)  within 100 days of completing the task in subsection (a) of this section, provide to the general public plain-language information regarding the regulatory roles, responsibilities, and processes of each agency, including which agency or agencies are responsible for oversight of different types of products developed with biotechnology, with case studies, as appropriate;

(c)  within 280 days of the date of this order, provide a plan to the Director of OMB, the ADPD, and the Director of OSTP with processes and timelines to implement regulatory reform, including identification of the regulations and guidance documents that can be updated, streamlined, or clarified; and identification of potential new guidance or regulations, where needed;

(d)  within 1 year of the date of this order, build on the Unified Website for Biotechnology Regulation developed pursuant to Executive Order 13874 by including on the website the information developed under subsection (b) of this section, and by enabling developers of biotechnology products to submit inquiries about a particular product and promptly receive a single, coordinated response that provides, to the extent practicable, information and, when appropriate, informal guidance regarding the process that the developers must follow for Federal regulatory review; and

(e)  within 1 year of the date of this order, and annually thereafter for a period of 3 years, provide an update regarding progress in implementing this section to the Director of OMB, the United States Trade Representative (USTR), the APNSA, the ADPD, and the Director of OSTP.  Each 1-year update shall identify any gaps in statutory authority that should be addressed to improve the clarity and efficiency of the regulatory process for biotechnology products, and shall recommend additional executive actions and legislative proposals to achieve such goals.

Sec. 9.  Reducing Risk by Advancing Biosafety and Biosecurity.  (a)  The United States Government shall launch a Biosafety and Biosecurity Innovation Initiative, which shall seek to reduce biological risks associated with advances in biotechnology, biomanufacturing, and the bioeconomy.  Through the Biosafety and Biosecurity Innovation Initiative — which shall be established by the Secretary of HHS, in coordination with the heads of other relevant agencies as determined by the Secretary — agencies that fund, conduct, or sponsor life sciences research shall implement the following actions, as appropriate and consistent with applicable law:

(i)   support, as a priority, investments in applied biosafety research and innovations in biosecurity to reduce biological risk throughout the biotechnology R&D and biomanufacturing lifecycles; and

(ii)  use Federal investments in biotechnology and biomanufacturing to incentivize and enhance biosafety and biosecurity practices and best practices throughout the United States and international research enterprises.

(b)  Within 180 days of the date of this order, the Secretary of HHS and the Secretary of Homeland Security, in coordination with agencies that fund, conduct, or sponsor life sciences research, shall produce a plan for biosafety and biosecurity for the bioeconomy, including recommendations to:

(i)   enhance applied biosafety research and bolster innovations in biosecurity to reduce risk throughout the biotechnology R&D and biomanufacturing lifecycles; and

(ii)  use Federal investments in biological sciences, biotechnology, and biomanufacturing to enhance biosafety and biosecurity best practices throughout the bioeconomy R&D enterprise.

(c)  Within 1 year of the date of this order, agencies that fund, conduct, or sponsor life sciences research shall report to the APNSA, through the Assistant to the President and Homeland Security Advisor, on efforts to achieve the objectives described in subsection (a) of this section.

Sec. 10.  Measuring the Bioeconomy.  (a)  Within 90 days of the date of this order, the Secretary of Commerce, through the Director of NIST, shall, in consultation with other agencies as determined by the Director, industry, and other stakeholders, as appropriate, create and make publicly available a lexicon for the bioeconomy, with consideration of relevant domestic and international definitions and with the goal of assisting in the development of measurements and measurement methods for the bioeconomy that support uses such as economic measurement, risk assessments, and the application of machine learning and other artificial intelligence tools.

(b)  The Chief Statistician of the United States, in coordination with the Secretary of Agriculture, the Secretary of Commerce, the Director of NSF, and the heads of other appropriate agencies as determined by the Chief Statistician, shall improve and enhance Federal statistical data collection designed to characterize the economic value of the United States bioeconomy, with a focus on the contribution of biotechnology to the bioeconomy.  This effort shall include:

(i)   within 180 days of the date of this order, assessing, through the Department of Commerce’s Bureau of Economic Analysis, the feasibility, scope, and costs of developing a national measurement of the economic contributions of the bioeconomy, and, in particular, the contributions of biotechnology to the bioeconomy, including recommendations and a plan for next steps regarding whether development of such a measurement should be pursued; and

(ii)  within 120 days of the date of this order, establishing an Interagency Technical Working Group (ITWG), chaired by the Chief Statistician of the United States, which shall include representatives of the Department of Agriculture, the Department of Commerce, OSTP, the NSF, and other appropriate agencies as determined by the Chief Statistician of the United States.

(A)  Within 1 year of the date of this order, the ITWG shall recommend bioeconomy-related revisions to the North American Industry Classification System (NAICS) and the North American Product Classification System (NAPCS) to the Economic Classification Policy Committee.  In 2026, the ITWG shall initiate a review process of the 2023 recommendations and update the recommendations, as appropriate, to provide input to the 2027 NAICS and NAPCS revision processes.

(B)  Within 18 months of the date of this order, the ITWG shall provide a report to the Chief Statistician of the United States describing the Federal statistical collections of information that take advantage of bioeconomy-related NAICS and NAPCS codes, and shall include recommendations to implement any bioeconomy-related changes as part of the 2022 revisions of the NAICS and NAPCS.  As part of its work, the ITWG shall consult with external stakeholders.

Sec. 11.  Assessing Threats to the United States Bioeconomy.  (a)  The Director of National Intelligence (DNI) shall lead a comprehensive interagency assessment of ongoing, emerging, and future threats to United States national security from foreign adversaries against the bioeconomy and from foreign adversary development and application of biotechnology and biomanufacturing, including acquisition of United States capabilities, technologies, and biological data.  As part of this effort, the DNI shall work closely with the Department of Defense to assess technical applications of biotechnology and biomanufacturing that could be misused by a foreign adversary for military purposes or that could otherwise pose a risk to the United States.  In support of these objectives, the DNI shall identify elements of the bioeconomy of highest concern and establish processes to support ongoing threat identification and impact assessments.

(b)  Within 240 days of the date of this order, the DNI shall provide classified assessments to the APNSA related to:

(i)   threats to United States national and economic security posed by foreign adversary development and application of biomanufacturing; and

(ii)  foreign adversary means of, and intended usages related to, acquisition of United States biotechnologies, biological data, and proprietary or precompetitive information.

(c)  Within 120 days of receiving the DNI’s assessments, the APNSA shall coordinate with the heads of relevant agencies as determined through the NSM-2 process to develop and finalize a plan to mitigate risks to the United States bioeconomy, based upon the threat identification and impact assessments described in subsection (a) of this section, the vulnerability assessments described in section 5(d) of this order, and other relevant assessments or information.  The plan shall identify where executive action, regulatory action, technology protection, or statutory authorities are needed to mitigate these risks in order to support the technology leadership and economic competitiveness of the United States bioeconomy.

(d)  The United States Government contracts with a variety of providers to support its functioning, including by contracting for services related to the bioeconomy.  It is important that these contracts are awarded according to full and open competition, as consistent with the Competition in Contracting Act of 1984 (Public Law 98-369, 98 Stat. 1175).  In accordance with these objectives, and within 1 year of the date of this order, the Director of OSTP, in coordination with the Secretary of Defense, the Attorney General, the Secretary of HHS, the Secretary of Energy, the Secretary of Homeland Security, the DNI, the Administrator of NASA, and the Administrator of General Services, shall review the national security implications of existing requirements related to Federal procurement — including requirements contained in the Federal Acquisition Regulation (FAR) and the Defense Federal Acquisition Regulation Supplement — and shall recommend updates to those requirements to the FAR Council, the Director of OMB, and the heads of other appropriate agencies as determined through the NSM-2 process.  The recommendations shall aim to standardize pre-award data collection to enable due diligence review of conflict of interest; conflict of commitment; foreign ownership, control, or influence; or other potential national security concerns.  The recommendations shall also include legislative proposals, as relevant.

(e)  The Director of OMB shall issue a management memorandum to agencies, or take other appropriate action, to provide generalized guidance based on the recommendations received pursuant to subsection (d) of this section.

Sec. 12.  International Engagement.  (a)  The Department of State and other agencies that engage with international partners as part of their missions shall undertake the following actions with foreign partners, as appropriate and consistent with applicable law — with a specific focus on developing countries, international organizations, and nongovernmental entities — to promote and protect both the United States and global bioeconomies:

(i)     enhance cooperation, including joint research projects and expert exchanges, on biotechnology R&D, especially in genomics;

(ii)    encourage regulatory cooperation and the adoption of best practices to evaluate and promote innovative products, with an emphasis on those practices and products that support sustainability and climate objectives;

(iii)   develop joint training arrangements and initiatives to support bioeconomy jobs in the United States;

(iv)    work to promote the open sharing of scientific data, including genetic sequence data, to the greatest extent possible in accordance with applicable law and policy, while seeking to ensure that any applicable access and benefit-sharing mechanisms do not hinder the rapid and sustainable development of innovative products and biotechnologies;

(v)     conduct horizon scanning to anticipate threats to the global bioeconomy, including national security threats from foreign adversaries acquiring sensitive technologies or data, or disrupting essential bio-related supply chains, and to identify opportunities to address those threats;

(vi)    engage allies and partners to address shared national security threats;

(vii)   develop, and work to promote and implement, biosafety and biosecurity best practices, tools, and resources bilaterally and multilaterally to facilitate appropriate oversight for life sciences, dual-use research of concern, and research involving potentially pandemic and other high-consequence pathogens, and to enhance sound risk management of biotechnology- and biomanufacturing-related R&D globally; and

(viii)  explore how to align international classifications of biomanufactured products, as appropriate, to measure the value of those products to both the United States and global bioeconomies.

(b)  Within 180 days of the date of this order, the Secretary of State, in coordination with the USTR and the heads of other agencies as determined by the Secretary, as appropriate, shall submit to the APNSA a plan to support the objectives described in subsection (a) of this section with foreign partners, international organizations, and nongovernmental entities.

Sec. 13.  Definitions.  For purposes of this order:

(a)  The term “agency” has the meaning given that term by 44 U.S.C. 3502(1).

(b)  The term “biotechnology” means technology that applies to or is enabled by life sciences innovation or product development.

(c)  The term “biomanufacturing” means the use of biological systems to develop products, tools, and processes at commercial scale.

(d)  The term “bioeconomy” means economic activity derived from the life sciences, particularly in the areas of biotechnology and biomanufacturing, and includes industries, products, services, and the workforce.

(e)  The term “biological data” means the information, including associated descriptors, derived from the structure, function, or process of a biological system(s) that is measured, collected, or aggregated for analysis.

(f)  The term “biomass” means any material of biological origin that is available on a renewable or recurring basis.  Examples of biomass include plants, trees, algae, and waste material such as crop residue, wood waste, animal waste and byproducts, food waste, and yard waste.

(g)  The term “biobased product” has the meaning given that term in 7 U.S.C. 8101(4).

(h)  The term “bioenergy” means energy derived in whole or in significant part from biomass.

(i)  The term “multiomic information” refers to combined information derived from data, analysis, and interpretation of multiple omics measurement technologies to identify or analyze the roles, relationships, and functions of biomolecules (including nucleic acids, proteins, and metabolites) that make up a cell or cellular system.  Omics are disciplines in biology that include genomics, transcriptomics, proteomics, and metabolomics.

(j)  The term “key R&D areas” includes fundamental R&D of emerging biotechnologies, including engineering biology; predictive engineering of complex biological systems, including the designing, building, testing, and modeling of entire living cells, cell components, or cellular systems; quantitative and theory-driven multi-disciplinary research to maximize convergence with other enabling technologies; and regulatory science, including the development of new information, criteria, tools, models, and approaches to inform and assist regulatory decision-making.  These R&D priorities should be coupled with advances in predictive modeling, data analytics, artificial intelligence, bioinformatics, high-performance and other advanced computing systems, metrology and data-driven standards, and other non-life science enabling technologies.

(k)  The terms “equity” and “underserved communities” have the meanings given those terms by sections 2(a) and 2(b) of Executive Order 13985.

(l)  The term “Tribal Colleges and Universities” has the meaning given that term by section 5(e) of Executive Order 14049 of October 11, 2021 (White House Initiative on Advancing Educational Equity, Excellence, and Economic Opportunity for Native Americans and Strengthening Tribal Colleges and Universities).

(m)  The term “Historically Black Colleges and Universities” has the meaning given that term by section 4(b) of Executive Order 14041 of September 3, 2021 (White House Initiative on Advancing Educational Equity, Excellence, and Economic Opportunity Through Historically Black Colleges and Universities).

(n)  The term “minority serving institution” has the meaning given that term by 38 U.S.C. 3698(f)(4).

(o)  The term “foreign adversary” has the meaning given that term by section 3(b) of Executive Order 14034 of June 9, 2021 (Protecting Americans’ Sensitive Data From Foreign Adversaries).

(p)  The term “life sciences” means all sciences that study or use living organisms, viruses, or their products, including all disciplines of biology and all applications of the biological sciences (including biotechnology, genomics, proteomics, bioinformatics, and pharmaceutical and biomedical research and techniques), but excluding scientific studies associated with radioactive materials or toxic chemicals that are not of biological origin or synthetic analogues of toxins.

Sec. 14.  General Provisions.  (a)  Nothing in this order shall be construed to impair or otherwise affect:

(i)   the authority granted by law to an executive department or agency, or the head thereof; or

(ii)  the functions of the Director of OMB relating to budgetary, administrative, or legislative proposals.

(b)  This order shall be implemented consistent with applicable law and subject to the availability of appropriations.

(c)  This order is not intended to, and does not, create any right or benefit, substantive or procedural, enforceable at law or in equity by any party against the United States, its departments, agencies, or entities, its officers, employees, or agents, or any other person.                           

JOSEPH R. BIDEN JR.

THE WHITE HOUSE,

  September 12, 2022."

https://www.whitehouse.gov/briefing-room/presidential-actions/2022/09/12/executive-order-on-advancing-biotechnology-and-biomanufacturing-innovation-for-a-sustainable-safe-and-secure-american-bioeconomy/

We need a new energy policy

A New Energy Policy

By 2019 the US was energy independent; meaning that we produced enough energy inside the country so that we did not depend on energy imports. The new administration in 2021 radically changed that policy due to a focused effort on abandoning fossil fuels in favor of renewables. Unfortunately, renewables (wind and solar) are, in many parts of the country, unreliable and intermittent energy sources. The U.S. economy is heavily dependent on fossil fuels because these energy sources generate 24-hour per day, continuous baseline power. Unfortunately, they are also sources of pollution and will eventually exhaust themselves.

This article isn’t about politics or the sometimes hysterical debate about climate change and pollution. It’s about how much time we have left before the United States undertakes a rational energy policy.

By rational energy policy I don’t mean relying on fossil fuels exclusively, or renewables exclusively. This country (and the world) needs to find reliable sources of clean, inexhaustible energy. For that we need to undertake an energy research program utilizing frontier physics.

99% of the research the Department of Energy sponsors is in the fossil fuel area. This must change. What must also change is the almost fanatical embrace of wind and solar and the abandonment of fossil fuels to the detriment of the economy, until continuous, clean energy sources are discovered. That’s why we need a total U.S. government and private industry research partnership to investigate new energy sources.

There are two areas we can research: one is the serious investigation of energy from the quantum particle flux, or the “zero-point” energy field that exists within the fabric of space. These investigations were being undertaken by the great inventor, Nikola Tesla, over a century ago, with some success. Now it is time for a serious, all-out research effort in this area.

The other area to investigate is magnetism. Permanent magnets hold energy; they can hold their charges for hundreds of years. We all understand the push-pull effect of a permanent magnet. Hold two magnets with their similar poles facing each other and you can feel the magnets pushing each other apart. Hold the magnets with opposite poles facing each other and the magnets snap together. A magnetic field induces an electric current. By arranging permanent magnets in an array, it should be possible for the push-pull magnetic effect to turn a rotor and generate electricity. This effect would be permanent because the energy of a magnet is permanent. Some genius just needs to determine how this is done.

The fossil-fuel crowd pooh-poohs and ridicules concepts like these (“perpetual motion machines,” “pie-in-the-sky lunacy,” “that technology is 50 years down the road”). The energy industry has been saying the latter for over 50 years! In the 21st century it is time to throw away such superannuated ideas. Mostly fossil fuels are ascendant because the fossil fuel industry is a $5T industry. That’s a lot of money.

The Failure of the Western Economic System

My guess is that the new research will not come from the West. Our economies have been gutted by insane industrial policies that have shipped our manufacturing base overseas, and an equally insane fiscal and monetary policy that prints fiat money in the trillions to solve economic problems. This is like running up your credit card debt past the maximum. Eventually the whole house of cards will collapse.  

I don’t care what you think of Vladimir Putin, he has got his head on straight when it comes to economic policy. In a speech given to the 25th St. Petersburg Economic Forum, he said,

Caught in the inflationary storm, developing nations have to ask themselves this question: Why bother exchanging goods for dollars and euros when they are losing value right before our eyes? Indeed the economy of imaginary wealth is being inevitably replaced by the economy of real valuables and hard assets.[emphasis mine] According to the IMF, today’s global foreign currency reserves contain 7.1 trillion dollars and 2.5 trillion euros. And this money is depreciating at an annual rate of 8%. Moreover, it can be stolen or confiscated at the whim of the US if it disapproves of something in a country’s policy. I think this has become a real threat for many countries that keep their gold and foreign exchange reserves in these currencies.”

https://twitter.com/MacroAlf/status/1566111781117775872

 Uh, yeah. Asia is organizing. The BRICS countries and their allies are organizing a different economic system, and a different reserve currency, independent of the West and our Central Bank system of fiat money by decree.

Let’s summarize what the Putin Monster said here: ‘The US and Europe are inflating their fiat money currencies so they are losing their value. We should abandon these worthless currencies and devise a new system based on currencies that represent real and tangible assets that people can use in their lives.’

Every word of this is true. Let’s take a look at what the US has done since the beginning of 2021: (a) Passed the “America Recovery Act” with 1.9 trillion printed dollars the government doesn’t have; (b) passed the “Infrastructure Act’” with 1.2 trillion freshly printed dollars the US doesn’t have; (c) Passed the $1.5 trillion “Supplemental Spending” bill with 1.5 trillion newly minted dollars the US doesn’t have. This was to make up for the proposed 5.8 trillion dollar spending bill for fiscal year 2022, which has over a trillion dollar deficit built into it! (The US will collect somewhere over 4 trillion in taxes this year).

Add that all up and you have almost 5 trillion dollars of unfunded spending over the next several years. Not all of this money will be spent in fiscal year 2022, but what will happen next year? More gigantic deficits. More continuing resolutions. No real budget, but continued spending in a desperate effort to save the carcass of the once-powerful American economy. Does anyone seriously think the government will stop overspending? Not a chance.

Resource Depletion

So – it looks like the new research that can make the planet energy independent using clean and unremitting energy sources might have to come from outside the US and Europe. Our hyper-financed economies are completely divorced from the reality of the true economy, as are our crazy, unsustainable energy policies based on polluting fossil fuels and intermittent wind and solar, which presently generate 12% of total U.S. energy. BTW, California has banned internal combustion engines by 2035. Governor Newsom also announced that owners of electric vehicles shouldn’t power up their batteries at home during the current heat wave! This is an example of the stupidity of current energy policies in the US. It’s also why we need to get some sense and initiate a massive research program that can make us independent of fossil fuels and intermittent wind and solar. We can’t afford to wait for other nations like China to do this, for governments like these are authoritarian and will impose concomitant political solutions that repress individual liberty and freedom. (If you think freedom and liberty are unfair, try living in an authoritarian state.)

The argument against a research program using a frontier physics approach is that the  US is blessed with huge natural gas deposits – in Pennsylvania, in Alaska, and in Texas. We have enough natural gas to last us almost a century. As of February 2022, according to the U.S. Energy Information Agency, natural gas was the United States' largest source of energy production, representing over 38 percent of all energy produced in the country, a 5% increase from 2016.

Hard-headed realists will ask why we need to spend billions on new research when we could develop our natural gas reserves and become completely energy independent again?

The answer is that a little investment now will generate a huge gain for the future. The US is not the only country in the world: we need to think about the entire human race. Moreover, the world’s consumption of fossil fuels is growing every year. Over the past 50 years, the world’s energy consumption has almost tripled, with oil and gas making up over half of all the energy consumed.

The US spent trillions of dollars fighting pointless, endless wars in Iraq and Afghanistan. How about we spend a little on an energy program that could make the entire human race energy independent, and keep our planet clean in the process? What’s the old saying? “Don’t shit where you eat.” Yeah. Don’t pollute this beautiful planet that sustains so much life upon it.

Such an energy program is do-able. We just have not made any investment in it, and have, in fact, suppressed frontier physics applications. The U.S. Patent Office is currently suppressing over 5,000 patents, many of them relating to energy.

Collectivization

There is currently a massive trend toward collectivization – authoritarian governments that promote a completely centralized approach to governance, such as the government in China. Global agencies such as the UN, the WHO, and the WEF are behind the effort to create hive-mind societies ruled from above. The current trend toward Transhumanism – augmenting human bodies ­– is also reflected in architecture. Huge cities like The Line are being proposed all over the world. These are cities separate from the natural environment, where collectivists can conduct social experiments and promote a Transhumanist way of life. Carlos Felipe Pardo, a senior adviser to the New Urban Mobility Alliance, says about The Line: “This solution is a little bit like wanting to live on Mars because things on Earth are very messy.” Check out the link, it’s a great NPR article.

There are many other proposed Transhumnist/Collectivist cities being proposed. Among them is Telosa, a planned city of 5 million in the southwest desert of the US, and the brainchild of billionaire Marc Lore. Telosa is based on the ideas of Henry George, a 19th century political economist and journalist, who believed that people should own the value they produce themselves, but that the economic value of land (including natural resources) should belong equally to all members of society. George’s ideas were enormously popular in the US in the 19th century. He critiqued private land ownership as a source of inequality. According to Bloomberg Businessweek, “Lore is particularly attracted to the strain of Georgism that involves creating a trust that holds the land in a community and uses the income it generates to fund social services.”

Whether or not these planned cities are Utopian or Dystopian, they are a dream to collectivists and Transhumanists like Yuval Hariri, who famously said, in a TED Talk,

Now, fast forward to the early 21st century when we just don’t need the vast majority of the population, because the future is about developing more and more sophisticated technology, like artificial intelligence [and] bioengineering, Most people don’t contribute anything to that, except perhaps for their data, and whatever people are still doing which is useful, these [Transhumanist] technologies increasingly will make redundant and will make it possible to replace the people.”

youtube.com/watch?v=w7DohVZS5Yo

Or maybe we can stuff them into planned cities like The Line and Telosa, where our betters can keep a watch over us.

Collectivization is intimately connected to resource depletion. One of the main arguments for planned cities like The Line is that they will conserve resources. Unfortunately, planned economies (command economies) are always found in authoritarian communist and fascist states. In a fascist state, the government rules in cooperation with wealthy oligarchs (similar to the corporate fascist state currently being developed in the US with cooperation from Big Tech, Big Media, and Big Pharma). Communist states engage in state-owned capitalism, as in China, where the central government subsumes the entire economy and owns every scrap of land, school, and factory. In both of these authoritarian collectivist states, the military enforces the diktats of the ruling government and the people have no freedom or liberty to make independent social or economic decisions. Erich Fromm tells us that a certain element of the population will always turn over their personal power to a dictator, but these societies always fail because individual initiative is stifled in the interests of the State/ruling class. Such societies are dead-on-arrival, and cannot continue long.

Conclusion

Collectivization is a natural outgrowth of resource depletion, and resource depletion/scarcity comes about through an over reliance on fossil fuels and intermittent (but at least renewable) energy sources like wind and solar.

It is time to release our dependence on both of these energy resources. Let’s utilize the creativity of the great US people and launch a program that will develop clean energy from unlimited energy sources. Ultimately a zero-point solution is the ideal, but using the power of permanent magnets to build portable magnetic generators for the home, or larger ones for an entire neighborhood or factory, are also attractive.

We can do it. Such a government-sponsored research program in cooperation with private industry has never been tried before. In fact, new inventions have been suppressed in favor of technologies that aren’t up to the task.

Instead of sending $80 billion to Ukraine to fight yet another regional war, let’s invest in the future of every human being on the planet. The US is still a world leader. Our scientific base has been politicized and compromised, but it is still intact.

The US can once again be an inspirational leader to the rest of the world. These new, frontier technologies are coming. They are inevitable if we want to build a prosperous, flourishing human civilization in cooperation with our beautiful planet.  

Scott Rosenberg at Axios reports that Facebook is changing its chronological organization of posts, and is going to “shape your online life around the algorithmically-sorted preferences of millions of strangers around the globe.”

Algorithms sorting posts? This is how Transhumanists want to run the world: Create a hive mind where individuality is subsumed by AIs and algos that know better what we should be thinking and reading and watching.

That's how TikTok sorts the videos it shows users, and that's largely how Facebook will now organize its home screen.”

That’s great! Tik Tok is owned by the Chinese Communist Party. All of the data you put up on Tik Tok goes to servers in China. The CCP has already created a totalitarian, technocratic state that ruthlessly suppresses dissent and individual opinion. In other words, the CCP and now Facebook are aligning their view of the world around the Hive Mind. Everybody think, speak, and act alike! Don’t rock the boat! The goal of Transhumanism and their allies in Big Tech and Big Medical, and the nutjobs in Davos, is to create an entire planetary society modeled on the CCP’s state fascism.

The dominant player in social media is transforming itself into a kind of digital mass media, in which the reactions of hordes of anonymous users, processed by machine learning, drive the selection of your content.”

Yup. That’s the “vision” of the sociopaths who have somehow gotten to the top of our governments and world institutions like the WEF, the WHO, and the UN.

Facebook and its rivals call this a ‘discovery engine’...For roughly a decade following the 2008 financial crisis, social networks — led by Facebook, with Twitter playing an important secondary role —dominated the internet's culture and economy. Their rise came with high hopes they might unleash waves of democratic empowerment and liberate self-expression around the world. But their chief impact emerged in the transformation of the media industry and the digital advertising business.”

Yes. And the suppression of free speech as the search algos became more and more authoritarian, suppressing “unwanted” content in the name of “protecting” people from “harmful” opinions.

The TikTok-style ‘discovery engine’ model shares many of the same problems. Posts are even less rooted in a web of social relationship. The larger the crowd, the louder the threshold for speech to be heard.”

But there is good news:

Messaging will continue to grow as the central channel for private, one-to-one and small group communications. Meta owns a big chunk of that market, too, thanks to Facebook Messenger and its ownership of WhatsApp. At the other end of the media spectrum, the ‘discovery engines’ run by TikTok and Meta will duke it out with streaming services to capture billions of eyeballs around the globe and sell that attention to advertisers.

All this leaves a vacuum in the middle — the space of forums, ad-hoc group formation and small communities that first drove excitement around internet adoption in the pre-Facebook era. Facebook's sunsetting of its own social network could open a new space for innovation on this turf, where relative newcomers like Discord are already beginning to thrive.”

Let the myopic giants in Big Tech and Big Medical, aligned with their nutjob Transhumanist buddies, continue to promote a World Hive Mind. They will capture a certain percentage of the population of course. But those of us with self-awareness will reject this dystopian future and create a better one, based on guaranteed human rights that come from God, not the state.

The UN, the World Health Organization, and their allies in the private sector such as Bill Gates and Jeff Bezos, are going all-out to impose a worldwide medical surveillance state

CNBC has announced that Jeff Bezos has just bought One Medical for $3.2 billion. In cash.

Amazon is acquiring One Medical for $18 a share, an all-cash deal that values the primary health-care provider at roughly $3.9 billion, the companies said Thursday.

The deal deepens Amazon’s presence in health care, which Neil Lindsay, senior vice president of Amazon Health Services, said is “high on the list of experiences that need reinvention.”

The e-commerce giant hopes to improve how people book appointments and the experience of being seen by a physician, Lindsay said in a statement.

“We love inventing to make what should be easy easier and we want to be one of the companies that helps dramatically improve the healthcare experience over the next several years,” he said.

https://www.cnbc.com/2022/07/21/amazon-to-buy-primary-health-care-provider-one-medical-for-roughly-3point9-billion.html

And if you believe that last sentence, I have a bridge in the Gobi desert to sell you.

First take a gander at the WHO's "Immunization Agenda." This document expresses the goals of Big Pharma and the Bill and Melinda Gates Foundation's GAVI (Global Alliance for Vaccines and Immunization), which is to vaccinate every man, woman, and child on planet earth. From the WHO document:

The Immunization Agenda 2030 (IA2030) sets an ambitious, overarching global vision and strategy for vaccines and immunization for the decade 2021–2030. It draws on lessons learnt, acknowledges continuing and new challenges posed by infectious diseases and capitalizes on new opportunities to meet those challenges. IA2030 positions immunization as a key contributor to people’s fundamental right to the enjoyment of the highest attainable physical and mental health and also as an investment in the future, creating a healthier, safer, more prosperous world for all. IA2030 aims to ensure that we maintain the hard-won gains and also that we achieve more – leaving no one behind, in any situation or at any stage of life. [emphasis mine]

IA2030 is intended to inspire and align the activities of community, national, regional and global stakeholders – national governments, regional bodies, global agencies, development partners, health care professionals, academic and research institutions, vaccine developers and manufacturers, the private sector and civil society. Its impact will be maximized by more effective and efficient use of resources, innovation to improve performance and measures to attain financial and programmatic sustainability. Success will depend on building and strengthening partnerships within and outside the health sector as part of a coordinated effort to improve access to high-quality, affordable primary health care, achieve universal health coverage and accelerate progress towards the 2030 Sustainable Development Goals (SDGs). [emphasis mine]

https://www.who.int/publications/m/item/immunization-agenda-2030-a-global-strategy-to-leave-no-one-behind

What does this mean? Health = vaccines. "Leaving no one behind" means vaccinating EVERYONE. A worldwide effort in all sectors of society -- using what the WHO calls "global stakeholders" -- that means Big Pharma, their billionaire buddies, and their captured agents in every sector of society -- to inject you with whatever vaccine they choose. At any time. By calling a "health emergency."

But that's not all. If you want to know more about the game plan of the elites for the Great Unwashed masses of humanity, read this document: The WHO's "Global genomic surveillance strategy for pathogens with pandemic and epidemic potential 2022–2032" at https://www.who.int/initiatives/genomic-surveillance-strategy (You can read this doc by downloading it from the above link).

This document outlines a plan to surveil all humans on the planet via a genomic analysis of each human body, as a part of the UN's "Sustainable Development" program.. Then, our betters can devise "vaccines" and other "useful" methods to eliminate pesky pathogens that might interfere with health -- or, maybe, to silence those who think, say, or do anything that goes against a planetary medical bureaucracy run from above by a few psychopaths.

From the document:

Global genomic surveillance strategy for pathogens with pandemic and epidemic potential, 2022–2032

The Strategy provides a high-level unifying framework to leverage existing capacities, address barriers and strengthen the use of genomic surveillance in the detection, monitoring and response to public health threats. Genomic surveillance is part of the broader surveillance and laboratory system, and its implementation should reinforce end-to-end capacities including sample collection, diagnostics, data sharing and analysis. The strategy aims to facilitate the connectivity between different disease control programs and surveillance networks. This interoperability will strengthen the cross-cutting essential public health laboratory functions underpinning genomics holistically. The strategy articulates the overarching goal, objectives and strategic actions needed. These are dependent on commitments from countries, partners and WHO for their implementation. [emphasis mine]

...

Information on public health threats needs to be rapidly available to allow for country, regional and global risk assessments that can quickly trigger public health interventions. The IHR (2005) obligates State Parties to develop national capacity for the detection, investigation and reporting through WHO of potential public health emergencies of international concern...

The strategy does not focus on one pathogen or a specific public health threat. Rather, it aims to provide a unifying vision for using genomics as a powerful addition to address public health needs for pandemic and epidemic preparedness and response broadly.... Ultimately, genomic surveillance is part of the broader surveillance and laboratory system, and its implementation should reinforce end-to-end capacities including sample collection, diagnostics, data sharing and analysis....

As the genomic surveillance use cases extend beyond pandemic and epidemic preparedness and response, the strategy aims to facilitate the connectivity with other disease control programmes and surveillance networks. This interoperability will strengthen the cross-cutting essential public health laboratory functions underpinning genomics holistically. [emphasis mine]

https://www.who.int/initiatives/genomic-surveillance-strategy

You get the idea. There's more insanity like this as you read the rest of the document.

The globalist plan for your future and the future of your children is outlined very succinctly in these publications. They're not hiding anything.

Will it work?

Nope. These are the delusional dreams of a few psychopaths who think it's their right to run the planet.

We won't let them.